Antinuclear antibody formation following administration of anti-tumor necrosis factor agents in Japanese patients with psoriasis

被引：5
|
作者：
Yanaba, Koichi [1 ]
Umezawa, Yoshinori [1 ]
Honda, Hiromi [1 ]
Sato, Reiko [1 ]
Chiba, Miki [1 ]
Kikuchi, Sota [1 ]
Asahina, Akihiko [1 ]
Nakagawa, Hidemi [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan
来源：
JOURNAL OF DERMATOLOGY | 2016年 / 43卷 / 04期
关键词：
ALPHA THERAPY; AUTOANTIBODIES; INFLIXIMAB;
D O I：
10.1111/1346-8138.13215
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [31] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [32] Effects of Anti-Tumor Necrosis Factor Therapy on Body Composition and Insulin Sensitivity in Patients With Psoriasis
    Kofoed, Kristian
    Clemmensen, Anders
    Mikkelsen, Ulla R.
    Simonsen, Lene
    Andersen, Ove
    Gniadecki, Robert
    ARCHIVES OF DERMATOLOGY, 2012, 148 (09) : 1089 - 1091
  • [33] Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
    Saraceno, Rosita
    Schipani, Caterina
    Mazzotta, Annamaria
    Esposito, Maria
    Di Renzo, Laura
    De Lorenzo, Antonino
    Chimenti, Sergio
    PHARMACOLOGICAL RESEARCH, 2008, 57 (04) : 290 - 295
  • [34] Combination therapy of cyclosporine and anti-tumor necrosis factor in psoriasis: a case series of 10 patients
    Barak, Eran Cohen
    Kerner, Miryam
    Rozenman, Dganit
    Ziv, Michael
    DERMATOLOGIC THERAPY, 2015, 28 (03) : 126 - 130
  • [35] Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
    Mitoma, Hiroki
    Horiuchi, Takahiko
    Tsukamoto, Hiroshi
    Tarnimoto, Yasuhiro
    Kimoto, Yasutaka
    Uchino, Ayumi
    To, Kentaro
    Harashima, Shin-ichi
    Hatta, Nobuaki
    Harada, Mine
    ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1248 - 1257
  • [36] Effectiveness of anti-Tumor Necrosis Factor agents in Pediatric Population with Uveitis
    Hajj-ali, Rula
    Choudhary, Maria
    Zeft, Andrew
    Spalding, Steven
    Srivastava, Sunil
    Lowder, Careen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [37] Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho, Jung
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 1 - 3
  • [38] Use of anti-tumor necrosis factor agents: A possible therapy for vitiligo
    Lv, Yajie
    Li, Qiang
    Wang, Lei
    Gao, Tianwen
    MEDICAL HYPOTHESES, 2009, 72 (05) : 546 - 547
  • [39] Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update
    Palazzi, Carlo
    D'Angelo, Salvatore
    Leccese, Pietro
    Padula, Angela
    Olivieri, Ignazio
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (02) : 191 - 196
  • [40] Perioperative use of anti-tumor necrosis factor-alfa agents
    Reinstadler, Amy
    Mau, Nicole
    Bhutani, Tina
    Talkin, Brenna
    Yamauchi, Paul
    Chiu, Melvin
    Peng, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 154 - 155
12345